Classification of an Alloalbumin

Albumin is the most abundant of the plasma proteins and has an important role in the maintenance of the oncotic pressure of the extracellular fluid and as a transporter of drugs, hormones and other molecules around the body. It is, however, not essential for life as several cases of analbuminaemia where there is an almost total lack of circulating albumin have been identified. 1 Over 100 albumin variants, based mainly on their electrophoretic mobility, have been described. These anomalies include analbuminaemia, the temporary appearance of oligomeric albumins formed during storage, the bisalbumins, and the genetically distinct albumin variants or the alloalbumins.i Nearly all alloalbumins are discovered as incidental findings during routine investigations and, while occasionally they may pose some technical problems in elucidating the nature of anomalous hormone or drug levels, they are rarely associated with any clinical manifestations. Albumin is a single polypeptide chain containing 585 amino acids with a molecular weight of approximately 66000 Da. The majority of the genetic albumin variants are the result of single point mutations in the primary gene sequence causing the substitution of one amino acid in the polypeptide chain, although translational defects such as failure of N-terminal signal peptide cleavage and premature chain termination at the C-terminal also contribute to the genetic variants.! However, only mutations which alter the charge on the albumin molecule will be recognized by electrophoretic techniques and some genetic variants may remain unidentified as silent alleles. In the past, when an alloalbumin was detected it was classified according to its migration in conventional alkaline pH

[1]  Scott R. Presnell,et al.  Origins of structural diversity within sequentially identical hexapeptides , 1993, Protein science : a publication of the Protein Society.

[2]  M. Vickers,et al.  Genetic variants of serum albumin: a study of albumin Kashmir. , 1992, Indian journal of biochemistry & biophysics.

[3]  E. De Clercq,et al.  Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. , 1991, Molecular pharmacology.

[4]  M. Galliano,et al.  Mutations in genetic variants of human serum albumin found in Italy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Vickers,et al.  Genetic characterization of an alloalbumin, albumin Kashmir, using gene amplification and allele-specific oligonucleotides. , 1990, The Biochemical journal.

[6]  N. Ishioka,et al.  The same substitution, glutamic acid----lysine at position 501, occurs in three alloalbumins of Asiatic origin: albumins Vancouver, Birmingham, and Adana. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[8]  Henry A. Erlich,et al.  Enzymatic amplification of ?-globin genomic sequences and restriction site analysis for diagnosis of , 1985 .

[9]  A. L. Tárnoky Genetic and drug-induced variation in serum albumin. , 1980, Advances in clinical chemistry.

[10]  J. Frohlich,et al.  Bisalbuminemia. A new molecular variant, albumin Vancouver. , 1978, Clinical chemistry.

[11]  P. Bennett,et al.  Distribution of albumin variants Naskapi amd Mexico among Aleuts, Frobisher Bay Eskimos, and Micmac, Naskapi, Mohawk, Omaha, and Apache Indians. , 1978, American journal of physical anthropology.

[12]  D. Lyster,et al.  Analbuminemia in a neonate. , 1975, The Journal of pediatrics.